101 related articles for article (PubMed ID: 9223730)
1. Correlation between susceptibility of primary HIV-1 isolates to autologous and heterologous neutralizing antibodies. Hospital Evandro Chagas AIDS Clinical Research Group.
Bongertz V; Costa CI; Santos VG; João Filho EC; Galvão-Castro B; Morgado MG
AIDS; 1997 Jul; 11(8):969-75. PubMed ID: 9223730
[TBL] [Abstract][Full Text] [Related]
2. Analysis of neutralizing and enhancing antibodies to human immunodeficiency virus type 1 primary isolates in plasma of individuals infected with env Genetic subtype B and E viruses in Thailand.
Auewarakul P; Louisirirotchanakul S; Sutthent R; Taechowisan T; Kanoksinsombat C; Wasi C
Viral Immunol; 1996; 9(3):175-85. PubMed ID: 8890476
[TBL] [Abstract][Full Text] [Related]
3. Neutralization susceptibility of B subtype variant B" primary HIV-1 isolates. The HEC/FIOCRUZ AIDS Clinical Research Group.
Bongertz V; Costa CI; Guimarães ML; Grinsztejn B; João Filho EC; Galvão-Castro B; Morgado MG
Scand J Immunol; 1998 Jun; 47(6):603-8. PubMed ID: 9652830
[TBL] [Abstract][Full Text] [Related]
4. Two PBMC-based neutralization assays depict low reactivity of both anti-V3 monoclonal antibodies and immune sera against HIV-1 primary isolates.
Candotti D; Rosenheim M; Huraux JM; Agut H
J Virol Methods; 1997 Feb; 64(1):81-93. PubMed ID: 9029533
[TBL] [Abstract][Full Text] [Related]
5. Regional clustering of shared neutralization determinants on primary isolates of clade C human immunodeficiency virus type 1 from South Africa.
Bures R; Morris L; Williamson C; Ramjee G; Deers M; Fiscus SA; Abdool-Karim S; Montefiori DC
J Virol; 2002 Mar; 76(5):2233-44. PubMed ID: 11836401
[TBL] [Abstract][Full Text] [Related]
6. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
7. Vertical HIV-1 transmission: importance of neutralizing antibody titer and specificity.
Bongertz V; Costa CI; Veloso VG; Grinsztejn B; João Filho EC; Calvet G; Pilotto JH; Guimarães ML; Morgado MG
Scand J Immunol; 2001 Mar; 53(3):302-9. PubMed ID: 11251889
[TBL] [Abstract][Full Text] [Related]
8. Epitopes corresponding to the envelope genetic subtype are present on the surface of free virions of HIV-1 group M primary isolates and can be detected in neutralization assays with extended incubation phases.
Davis D; Donners H; Willems B; Vermoesen T; Heyndrickx L; Colebunders R; van der Groen G
J Med Virol; 2003 Nov; 71(3):332-42. PubMed ID: 12966537
[TBL] [Abstract][Full Text] [Related]
9. Immunization with envelope subunit vaccine products elicits neutralizing antibodies against laboratory-adapted but not primary isolates of human immunodeficiency virus type 1. The National Institute of Allergy and Infectious Diseases AIDS Vaccine Evaluation Group.
Mascola JR; Snyder SW; Weislow OS; Belay SM; Belshe RB; Schwartz DH; Clements ML; Dolin R; Graham BS; Gorse GJ; Keefer MC; McElrath MJ; Walker MC; Wagner KF; McNeil JG; McCutchan FE; Burke DS
J Infect Dis; 1996 Feb; 173(2):340-8. PubMed ID: 8568294
[TBL] [Abstract][Full Text] [Related]
10. Lack of autologous neutralizing antibodies in the cerebrospinal fluid of HIV-1 infected individuals.
von Gegerfelt A; Chiodi F; Keys B; Norkrans G; Hagberg L; Fenyö EM; Broliden K
AIDS Res Hum Retroviruses; 1992 Jun; 8(6):1133-8. PubMed ID: 1503825
[TBL] [Abstract][Full Text] [Related]
11. Intrasubtype B HIV-1 Superinfection Correlates with Delayed Neutralizing Antibody Response.
Wagner GA; Landais E; Caballero G; Phung P; Kosakovsky Pond SL; Poignard P; Richman DD; Little SJ; Smith DM
J Virol; 2017 Sep; 91(17):. PubMed ID: 28615205
[TBL] [Abstract][Full Text] [Related]
12. Neutralization of primary HIV-1 isolates by anti-envelope monoclonal antibodies.
D'Souza MP; Milman G; Bradac JA; McPhee D; Hanson CV; Hendry RM
AIDS; 1995 Aug; 9(8):867-74. PubMed ID: 7576320
[TBL] [Abstract][Full Text] [Related]
13. Neutralization of HIV-1 subtypes: implications for vaccine formulations.
Smith TL; van Rensburg EJ; Engelbrecht S
J Med Virol; 1998 Nov; 56(3):264-8. PubMed ID: 9783696
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing antibody response during human immunodeficiency virus type 1 infection: type and group specificity and viral escape.
Arendrup M; Sönnerborg A; Svennerholm B; Akerblom L; Nielsen C; Clausen H; Olofsson S; Nielsen JO; Hansen JE
J Gen Virol; 1993 May; 74 ( Pt 5)():855-63. PubMed ID: 7684062
[TBL] [Abstract][Full Text] [Related]
15. Neutralization sensitivity of HIV-1 subtype B' clinical isolates from former plasma donors in China.
OuYang Y; Sun J; Huang Y; Lu L; Xu W; Hu X; Hong K; Jiang S; Shao Y; Ma L
Virol J; 2013 Jan; 10():10. PubMed ID: 23289760
[TBL] [Abstract][Full Text] [Related]
16. Resistance to antibody neutralization in HIV-2 infection occurs in late stage disease and is associated with X4 tropism.
Marcelino JM; Borrego P; Nilsson C; Família C; Barroso H; Maltez F; Doroana M; Antunes F; Quintas A; Taveira N
AIDS; 2012 Nov; 26(18):2275-84. PubMed ID: 23151495
[TBL] [Abstract][Full Text] [Related]
17. Potent autologous and heterologous neutralizing antibody responses occur in HIV-2 infection across a broad range of infection outcomes.
de Silva TI; Aasa-Chapman M; Cotten M; Hué S; Robinson J; Bibollet-Ruche F; Sarge-Njie R; Berry N; Jaye A; Aaby P; Whittle H; Rowland-Jones S; Weiss R
J Virol; 2012 Jan; 86(2):930-46. PubMed ID: 22072758
[TBL] [Abstract][Full Text] [Related]
18. Neutralization resistant HIV-1 primary isolates from antiretroviral naïve chronically infected children in India.
Makhdoomi MA; Singh D; Nair Pananghat A; Lodha R; Kabra SK; Luthra K
Virology; 2016 Dec; 499():105-113. PubMed ID: 27643887
[TBL] [Abstract][Full Text] [Related]
19. Frequent and early HIV-1MN neutralizing capacity in sera from Dutch HIV-1 seroconverters is related to antibody reactivity to peptides from the gp120 V3 domain.
Zwart G; Back NK; Ramautarsing C; Valk M; van der Hoek L; Goudsmit J
AIDS Res Hum Retroviruses; 1994 Mar; 10(3):245-51. PubMed ID: 8018385
[TBL] [Abstract][Full Text] [Related]
20. Unique mutational patterns in the envelope alpha 2 amphipathic helix and acquisition of length in gp120 hypervariable domains are associated with resistance to autologous neutralization of subtype C human immunodeficiency virus type 1.
Rong R; Gnanakaran S; Decker JM; Bibollet-Ruche F; Taylor J; Sfakianos JN; Mokili JL; Muldoon M; Mulenga J; Allen S; Hahn BH; Shaw GM; Blackwell JL; Korber BT; Hunter E; Derdeyn CA
J Virol; 2007 Jun; 81(11):5658-68. PubMed ID: 17360739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
